Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance.
Hill, David P
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance. [electronic resource] - BMC cancer Nov 2019 - 1039 p. digital
Publication Type: Journal Article
1471-2407
10.1186/s12885-019-6278-9 doi
Animals
Antineoplastic Agents--therapeutic use
Biological Evolution
Cell Line, Tumor
Cisplatin--therapeutic use
Conserved Sequence
Drug Resistance, Neoplasm--genetics
Epithelial-Mesenchymal Transition--genetics
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Genomics--methods
Humans
Mice
Rats
Receptors, Androgen--metabolism
Triple Negative Breast Neoplasms--drug therapy
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance. [electronic resource] - BMC cancer Nov 2019 - 1039 p. digital
Publication Type: Journal Article
1471-2407
10.1186/s12885-019-6278-9 doi
Animals
Antineoplastic Agents--therapeutic use
Biological Evolution
Cell Line, Tumor
Cisplatin--therapeutic use
Conserved Sequence
Drug Resistance, Neoplasm--genetics
Epithelial-Mesenchymal Transition--genetics
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Genomics--methods
Humans
Mice
Rats
Receptors, Androgen--metabolism
Triple Negative Breast Neoplasms--drug therapy